This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Covidien Announces Investor Meeting Agenda

Stocks in this article: COV

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the agenda for its investor meeting on Thursday, September 12, 2013. The event will be held at Cipriani, 55 Wall Street, New York, NY. A webcast of the presentations will begin at approximately 2:20 pm ET and will conclude by 5:00 pm ET.

The program will begin with rotational sessions where attendees will visit Covidien's product displays, hear from industry experts discussing how Covidien technology is being used and learn about the Company’s early stage growth opportunities. Following these sessions will be formal presentations by Covidien's Chairman, President and Chief Executive Officer José (Joe) E. Almeida and other Covidien leaders, as well as Q&A with members of the senior management team.

For those investors who are unable to attend the meeting in person, but would like to ask a question of the management team during the meeting, questions can be emailed to 2013cov@gmail.com.

Agenda

9:30 a.m. Registration Opens10:00 a.m. – 2:15 p.m. Rotational Sessions

  • Product Displays; Senior Management interaction
  • Clinical Perspectives on Covidien Technology
  • Covidien’s Early Stage Growth Opportunities

2:20 p.m. Senior Management Presentations

  • José (Joe) E. Almeida, Chairman, President and CEO
  • Brian D. King, President, Emerging Markets
  • Q&A with Senior Management Team

4:05 p.m. Charles J. Dockendorff, Chief Financial Officer4:30 p.m. Financial Q&A5:00 p.m. Presentations and webcast end

Advanced registration is required and attendance will be limited to those who register in advance. To register for the meeting, please go to the following website: http://survey.covidien.com/f/537189/1e8a/.

Individuals who are unable to attend the meeting in person will be able to view a live video and webcast at Covidien’s website: http://investor.covidien.com. A replay of the presentations and the presentation materials will be available at the same website following the conclusion of the meeting.

ABOUT COVIDIEN

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading products in medical devices and supplies. With 2012 revenue of $9.9 billion, Covidien has 38,000 employees worldwide in 70 countries, and its products are sold in over 140 countries. Please visit www.covidien.com to learn more about our business.



1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,659.47 +302.60 1.74%
S&P 500 2,048.46 +35.57 1.77%
NASDAQ 4,731.8750 +87.5630 1.89%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs